describes the preliminary experience of a pharmacy in a university-affiliated community hospital in implementing selected Choosing Wisely recommendations. The project was limited to the assessment, selection, and implementation of recommendations; evaluation of patient outcomes was beyond its scope.
DESCRIPTION OF THE PROJECT Choosing Wisely at North York General Hospital
North York General Hospital (NYGH) is a 420-bed community academic hospital providing a wide range of acute care, ambulatory, and long-term care services. NYGH was one of the early adopters of Choosing Wisely Canada, launching its own campaign in June 2014. The hospital used 4 concurrent strategies to guide implementation of the campaign: leadership engagement, idea generation and evaluation, front-line staff engagement, and patient engagement ( Figure 1 ).
Leadership engagement started with the development of a hospital-wide interprofessional Choosing Wisely Committee to support the campaign. The committee members consisted of representatives from the senior leadership team, medical chiefs, directors of clinical programs and departments, a patient advisor, and supporting departments such as Informatics and Corporate Communications. The committee provided clinical and administrative leadership by reviewing pertinent Choosing Wisely recommendations and identifying and prioritizing those with the most potential impact at NYGH, engaging staff, and leading hospital-wide initiatives. The first project involved examination of the utilization and appropriateness of laboratory tests and diagnostic imaging. Individual departments, including the Pharmacy Department, were asked to identify their lists of 
Medication-Related Choosing Wisely Recommendations
In May 2014, the Pharmacy Department reviewed a total of 326 recommendations from 60 societies involved in the Choosing Wisely and Choosing Wisely Canada campaigns. Of the 52 medication-related recommendations, 28 were considered relevant to inpatients. On the basis of anecdotal observation of overutilization of certain classes of medications (from drug utilization data) and the perceived lack of benefit and/or safety of these medications, the pharmacy leadership team finalized the following 5 recommendations for implementation:
• Don't use stool softeners alone to prevent opioid-induced constipation.
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• Don't maintain long-term proton pump inhibitor (PPI) therapy for gastrointestinal symptoms without an attempt to stop/reduce PPI at least once per year in most patients. 6 • Don't take a multivitamin, vitamin E, or ß-carotene to prevent cardiovascular disease or cancer. 7 • Don't use benzodiazepines or other sedative-hypnotics in older adults as first choice for insomnia, agitation, or delirium. 8 • Don't use antipsychotics as first choice to treat behavioural and psychological symptoms of dementia (BPSD).
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Implementing the Choosing Wisely Recommendations
Strategies for implementing Choosing Wisely recommendations consisted of formulary management and revision of electronic order sets. Proposed changes to the formulary underwent rigorous reviews by the Pharmacy and Therapeutics Committee and the Medical Advisory Committee. In addition, the hospital provided support to the Informatics Department in updating medication choices in electronic order sets and augmenting order sets with clinical notes based on Choosing Wisely recommendations.
The pharmacy leadership team (including the 3 authors of this report) led the medication-related Choosing Wisely initiatives. The organization equipped them with tools to carry out this project by enrolling them in knowledge translation educational programs. These educational events also gave the team leaders opportunities for networking with pharmacists from other institutions and sharing Choosing Wisely implementation experiences. Engagement of clinical pharmacists was achieved by providing educational sessions on the Choosing Wisely Campaign, the proposed medication-related initiatives, and their associated evidence-based resources. The clinical pharmacists were consulted to identify the potential impact of the initiatives and anticipated challenges with their implementation. The clinical pharmacists were also provided with resources such as patient information leaflets produced by Choosing Wisely Canada, which could be used when reviewing recommendations with patients.
Specific strategies for implementing each of the 5 Choosing Wisely recommendations are described below.
Stool Softeners
Although docusate products have been widely used for the management of constipation, a published review of the evidence showed that this drug is not more effective than placebo in the prevention or management of constipation. 9 Guidelines on the management of constipation either omit stool softeners as options 10 or describe low evidence for their use. 11 At NYGH, docusate products were on the formulary and were available in 55 order sets. After completion of an evidencebased class review of laxatives at NYGH, the pharmacy leadership group recommended that docusate be removed from the order sets to prevent initiation of this medication. This suggestion was approved by the Medical Advisory Committee in April 2015 and implemented in September 2015. Order sets for constipation management were updated to guide prescribing of more effective alternatives, such as osmotic or stimulant laxatives. Use of docusate has declined steadily over time ( Figure  2 ), and the drug was eventually removed from the formulary in February 2017. The effect of this change in recommendation on patient outcomes has not yet been evaluated.
Proton Pump Inhibitors
Several guidelines, 12, 13 including those of Choosing Wisely Canada, 6 have recommended against long-term PPI therapy for gastrointestinal symptoms without attempts to reduce or stop therapy, except for high-risk patients. Risks that have been reported to be associated with PPI therapy include communityacquired pneumonia, fractures, Clostridium difficile infections, vitamin B 12 deficiency, and hypomagnesemia. 13 A 5-month deprescribing pilot was conducted at NYGH between March and August 2016 on a medicine unit where patients have been deemed medically stable and designated as needing an alternate level of care (ALC). ALC patients were selected for this pilot because attempted deprescribing of PPI was considered more appropriate for patients in whom all acute medical issues had been resolved. The unit pharmacist evaluated the indication for PPI in each patient and, using the PPI deprescribing algorithm as a guide, 13 determined whether deprescribing should be proposed. The pharmacist then discussed the deprescribing recommendations with the patient, using Choosing Wisely patient information leaflets or similar resources. The interdisciplinary team monitored the patient during the deprescribing process until the time of discharge. The deprescribing intervention and follow-up plan were conveyed to the next health care provider through the discharge information package. Pharmacists made a deprescribing recommendation for 20 patients; of these, 12 (60%) were accepted, resulting in PPI discontinuation for 10 patients and dose reductions for 2 patients.
14 Although attempting PPI deprescribing could be a challenge in an acute care setting, deprescribing of these drugs can be successfully implemented in selected patients (e.g, those designated as ALC). These strategies can be used for ALC patients in other units of the hospital or in similar populations in other hospitals.
Multivitamins
Vitamin and mineral supplements are commonly used. One study reported that 40.1% of adult Canadians took supplements. 15 Although discontinuation of multivitamins is not a current Choosing Wisely Canada recommendation, the American College of Preventive Medicine has suggested as 1 of its top 5 recommendations, "Don't take a multi-vitamin, vitamin E or beta-carotene to prevent cardiovascular disease or cancer." 7 The pharmacy leadership group at NYGH discussed the role of vitamins and minerals in the hospital setting as an idea for the Choosing Wisely campaign. The concern was the widespread use of multivitamin products and a lack of evidence for their use. [16] [17] [18] Additionally, multivitamins that contain minerals pose a risk of drug interactions, thus generating the need for rescheduling medication administration times. An audit showed that some patients were started on multivitamin therapy through order sets. This observation prompted a review of all order sets containing an order for oral multivitamin. It was found that 19 order sets had a default for oral multivitamin.
The CPOE [Computerized Provider Order Entry] Order Set
Team worked with the clinical dietitians to assess the need for default multivitamin orders, and eventually had the default setting removed from 10 of the order sets. Examples of order sets from which the multivitamin default was removed were admission order sets in general medical care and for patients with stroke, seizures, or abdominal pain. The default was retained in order sets where multivitamin therapy was considered appropriate, such as those for patients admitted because of alcohol withdrawal, patients known to have significant alcohol use, and patients with eating disorders or requiring enteral nutritional support. Use of multivitamins has decreased by about 19% since this change (Figure 3 ).
Benzodiazepines
The adverse effects associated with benzodiazepines are well documented. These drugs are associated with an increased risk of falls, hip fractures, motor vehicle accidents, and cognitive impairment. 8 Prescribing or discontinuing these medications in hospital may have a substantial impact on their long-term use. 8 Choosing Wisely Canada recommends that benzodiazepines and other sedative-hypnotics not be used in older adults as the first choice for insomnia, agitation, or delirium. 8 There is no therapy for the treatment of insomnia that is both safe and effective. To provide a safer alternative to benzodiazepines, melatonin was added to the NYGH drug formulary in April 2015. Although the evidence regarding its efficacy is not robust, melatonin was at least partially effective in half of the elderly inpatients included in an internal retrospective chart review evaluation. 19 Insomnia order sets were modified to remove all benzodiazepine options, which prevented patients from being started and discharged on this class of medications. Melatonin and nonpharmacological measures such as ear plugs were added to the order sets. Additional warnings were included in the order sets to remind clinicians that benzodiazepines should not be used in the management of delirium, except in cases of alcohol or benzodiazepine withdrawal. Further analyses will be undertaken at NYGH to evaluate the trend in use of benzodiazepines, other hypnotics, and melatonin in the management of insomnia in hospitalized older adults. In particular, the number of orders by patient-days for each class of medications will be compared before and after the order set changes.
Antipsychotics
Antipsychotics are associated with increased risks of mortality and cardiovascular events when used in individuals with dementia. 20, 21 The benefit of antipsychotics in the management of BPSD 22, 23 and delirium 24 is limited. As such, the use of antipsychotics should be reserved for cases in which nonpharmacological measures have failed and patients pose an imminent threat to themselves or others. 8, 12 Deprescribing of antipsychotics has been a goal for ALC patients at NYGH. The unit pharmacist worked with the physicians and the interprofessional team to identify patients for whom antipsychotics had been prescribed for BPSD or delirium. If the use of antipsychotics was deemed necessary, the antipsychotic therapy was reassessed on a regular basis for tapering and discontinuation whenever it was possible. At NYGH, nonpharmacological approaches, such as the Montessori Method, gentle persuasion, and music therapy have been preferred over pharmacotherapy; the hospital has found these nonpharmacological approaches to be effective in individual cases after antipsychotics have been successfully tapered off. Although formal research studies have not been conducted, preliminary observations by the unit pharmacist have indicated that deprescribing of antipsychotics was successful in about 80% of the patients with initiation of treatment for delirium, because the condition eventually resolved and antipsychotics were no longer required. Among patients with BPSD, however, the success rate for tapering off antipsychotics has been closer to 60%.
IMPLICATIONS AND SIGNIFICANCE FOR PRACTICE
The successful adoption of Choosing Wisely initiatives at NYGH has largely been attributed to organization-wide support, stakeholder education, and availability of resources. The NYGH Choosing Wisely Committee is dedicated to providing ongoing clinical and leadership support for this campaign, by meeting regularly to develop quality improvement projects to help sustain new initiatives. Communication of key milestones, identification of benefits achieved, and implementation of new initiatives are key elements for continuing staff engagement. Furthermore, collaboration with other institutions and agencies (e.g., government) may help to accelerate the implementation and spread of proven research evidence into broader practice. Since April 2016, NYGH has been the lead site, in partnership with the Adopting Research to Improve Care (ARTIC) program, in a project to disseminate NYGH Choosing Wisely knowledge and experience to 4 member hospitals and 6 affiliated family health teams. 25 The process of reviewing Choosing Wisely recommendations, drug utilization data, and practices within the hospital helped the Pharmacy Department to focus on minimizing the use of a selected group of unnecessary drug therapies. Several challenges were recognized during the preliminary implementation process. Not all Choosing Wisely recommendations are appropriate for adoption in the acute care setting. Therefore, successful adoption of Choosing Wisely Canada recommendations will require a proper feasibility assessment and use of multimodal strategies. Furthermore, certain Choosing Wisely recommendations are suitable for centre-wide implementation, whereas others are appropriate only for selected groups of patients. Our experience in adopting Choosing Wisely recommendations showed that the effects of each recommendation may vary, depending on factors such as cultural shifts and stakeholders' buy-in. Pharmacists may need more time for some interventions, such as PPI deprescribing, if the interventions involve identifying indications for particular medications to determine the appropriateness of deprescribing in individual patients. Although it is important for an organization to have ongoing evaluation of the effects of changes implemented, meaningful evaluation of patient outcomes requires additional staff resources and time, which may not always be available. Patient outcomes and satisfaction with care were not evaluated in the current study.
PHARMACISTS' ROLE AND FUTURE DIRECTION
Pharmacy societies in Canada have yet to identify the "top 5" Choosing Wisely recommendations, although the Canadian Pharmacists Association has asked pharmacists for their input on development of such a list. 26 To date, 2 pharmacy societies, the Society of Hospital Pharmacists of Australia 27 and the American Society of Health-System Pharmacists, 28 have contributed official Choosing Wisely recommendations. These 2 sets of recommendations are presented in Box 2.
Pharmacists are well positioned to promote the Choosing Wisely campaign. As providers of pharmaceutical care, we ensure, to the extent feasible, that all patients' medications are indicated, effective, safe, and convenient to take. Our endeavours in medication review and medication reconciliation, stewardship programs, and deprescribing initiatives can be used as starting points in identifying practices that we should question. As such, we may want to adopt the motto "Don't fill it before you talk about it."
